                </a></li></ul></div><p><strong>Figure 4.  <span>Combination Therapy led to an increase in FOXP3 and IL-10 gene transcription in CD4+CD25+ cells, whereas it also led to and increase in IL-10 transcription in CD4+CD25− cells.</span></strong></p><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1"></a><p>TNFα transcription was abolished by the combination therapy as well as by a full course of Etanercept treatment.</p>
<a id="article1.body1.sec3.sec4.fig1.caption1.p2" name="article1.body1.sec3.sec4.fig1.caption1.p2"></a><p>Results are expressed as the induction index (marker/housekeeping gene GAPDH) of HSP60 peptide 180-188 stimulation subtracted by media alone as measured by Real Time Quantitative PCR.</p>
<a id="article1.body1.sec3.sec4.fig1.caption1.p3" name="article1.body1.sec3.sec4.fig1.caption1.p3"></a><p>IL-10 production Combination therapy vs. Etanercept treatment p = 0.002.</p>
<a id="article1.body1.sec3.sec4.fig1.caption1.p4" name="article1.body1.sec3.sec4.fig1.caption1.p4"></a><p>N = 2–4 per treatment.</p>
